Second Genome logo

Second Genome

Second Genome is a company that is developing microbiome modulators for infection, immunity and metabolic diseases.

3

Funding Rounds

$67.5m

Money raised

Overview

Second Genome is a company that is developing microbiome modulators for infection, immunity and metabolic diseases.

Funding

Funding series

Funding Series Analysis

The company Second Genome has raised a total of $16.5m in funding over 3 rounds.

Key Insights:

  • Second Genome Series A round: $11.5m
  • Second Genome funding round, August 2011: $5m
  • Second Genome Series B round, April 2016: $51m
Second Genome logo
Second Genome Series A round $11.5m
Second Genome logo
Second Genome funding round, August 2011 $5m
Second Genome logo
Second Genome Series B round, April 2016 $51m